University of Oxford to assess COVID-19 vaccine response among children for first time
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Study reveals how coronavirus could hijack human cells
These findings may lead to the development of new drugs for treating COVID-19
COVID-19 mRNA vaccines can face uptake issues over disinformation and safety concerns: GlobalData
Experts estimate that achieving herd immunity to COVID-19 will required upwards of 70–90 per cent of the population to have…
UK researchers find semaglutide could be a ‘game changer’ drug to fight obesity
The drug, semaglutide, works by hijacking the body's own appetite-regulating system in the brain leading to reduced hunger and…
Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating polyneuropathy
It is the only FDA-approved intravenous immunoglobulin with two maintenance dosing options for CIDP
Strides gets USFDA approval for Prednisone Tablets
Prednisone is a corticosteroid used as an anti-inflammatory or an immunosuppressant medication to treat different conditions such…
PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients
Clinical trial report to be submitted to Drug Controller General of India on February 22, 2021
COVID-19 vaccines worth Rs 338 crores exported from India so far: Piyush Goyal
The exports include grant of the vaccine doses to friendly countries and commercial shipments.
Alembic Pharma subsidiary, Alembic Global Holding SA gets USFDA final nod for Treprostinil injection
Treprostinil injection is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with…
Biocon Biologics and Viatris get EC Approval for Kixelle, biosimilar insulin Aspart
Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1…
COVID-19 vaccine from AstraZeneca/Oxford may see more global uptake due to good efficacy: GlobalData
GlobalData expects that the low cost of the AstraZeneca/Oxford vaccine will allow it to be used in low-income countries – where…
US buys additional 100 million doses COVID-19 vaccine from Moderna
Total of 300 million doses ordered by the US government to date, the company has supplied over 41 million doses so far
The Brexit effect
Brexit is finally a reality and though India Pharma Inc expects some glitches in the short-term, it is optimistic about its impact…
Celltrion develops neutralising antibody cocktail to tackle COVID-19 variant spread
CT-P59 demonstrated neutralising capability against key emerging mutations, including the UK variant in addition to six variant…
Reason for COVID-19 cases downturn in India is unclear: GlobalData
In India, the current rate of new cases is 10 per one million population, in marked contrast to the US, where the rate is 370 new…
WHO recommends AstraZeneca COVID-19 vaccine for widespread use
South Africa this week paused its rollout of the AstraZeneca vaccine after data from a small trial showed it did not protect…
India will endeavour to meet Canada’s vaccine needs, Modi tells Trudeau
India, with several vaccine manufacturing facilities, is fast emerging as a key supplier of shots to the world
Glenmark gets USFDA approval for Clindamycin Phosphate Gel
It is an antibiotic indicated for the treatment of acne
Laurus Labs wins Golden Peacock Award for Excellence in Corporate Governance
This is the first year that Laurus Labs has won this award, instituted in 1991 by the Institute of Directors (IOD), India
Parexel and NeoGenomics announce partnership to improve clinical trials
The companies will collaborate to optimise study designs and speed up patient matching in oncology clinical trials